Perry Megan, Ghosal Gargi
Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.
Fred and Pamela Buffett Cancer Center, Omaha, NE, United States.
Front Mol Biosci. 2022 Jun 15;9:916697. doi: 10.3389/fmolb.2022.916697. eCollection 2022.
DNA-protein crosslinks (DPCs) are deleterious DNA lesions that occur when proteins are covalently crosslinked to the DNA by the action of variety of agents like reactive oxygen species, aldehydes and metabolites, radiation, and chemotherapeutic drugs. Unrepaired DPCs are blockades to all DNA metabolic processes. Specifically, during DNA replication, replication forks stall at DPCs and are vulnerable to fork collapse, causing DNA breakage leading to genome instability and cancer. Replication-coupled DPC repair involves DPC degradation by proteases such as SPRTN or the proteasome and the subsequent removal of DNA-peptide adducts by nucleases and canonical DNA repair pathways. SPRTN is a DNA-dependent metalloprotease that cleaves DPC substrates in a sequence-independent manner and is also required for translesion DNA synthesis following DPC degradation. Biallelic mutations in SPRTN cause Ruijs-Aalfs (RJALS) syndrome, characterized by hepatocellular carcinoma and segmental progeria, indicating the critical role for SPRTN and DPC repair pathway in genome maintenance. In this review, we will discuss the mechanism of replication-coupled DPC repair, regulation of SPRTN function and its implications in human disease and cancer.
DNA-蛋白质交联(DPCs)是有害的DNA损伤,当蛋白质通过活性氧、醛类和代谢产物、辐射以及化疗药物等多种因素的作用与DNA共价交联时就会发生。未修复的DPCs会阻碍所有DNA代谢过程。具体而言,在DNA复制过程中,复制叉会在DPCs处停滞,并且容易发生叉状塌陷,导致DNA断裂,进而引发基因组不稳定和癌症。复制偶联的DPC修复包括通过蛋白酶(如SPRTN)或蛋白酶体降解DPC,以及随后通过核酸酶和经典DNA修复途径去除DNA-肽加合物。SPRTN是一种依赖DNA的金属蛋白酶,它以序列无关的方式切割DPC底物,并且在DPC降解后的跨损伤DNA合成中也是必需的。SPRTN的双等位基因突变会导致鲁伊斯-阿尔夫斯(RJALS)综合征,其特征为肝细胞癌和节段性早衰,这表明SPRTN和DPC修复途径在基因组维持中起着关键作用。在这篇综述中,我们将讨论复制偶联的DPC修复机制、SPRTN功能的调节及其在人类疾病和癌症中的意义。